Care Across the Lifespan I
Medication Review
Review the FDA approved use of the following medicines related to treating mood disorders.
|
Depression |
|
Premenstrual dysphoric disorder |
Seasonal affective disorder (MDD with Seasonal Variation) |
|
|
agomelatine amitriptyline amoxapine aripiprazole (adjunct) brexpiprazole (adjunct)bupropion citalopram clomipramine cyamemazine desipramine desvenlafaxine dothiepindoxepin duloxetine escitalopram fluoxetine fluvoxamine iloperidone imipramine isocarboxazid ketamine lithium (adjunct) l-methylfolate (adjunct)
|
lofepramine maprotiline mianserin milnacipran mirtazapine moclobemide nefazodone nortriptyline paroxetine phenelzine protriptyline quetiapine (adjunct) reboxetine selegiline sertindole sertraline sulpiride tianeptine tranylcypromine trazodone trimipramine venlafaxine vilazodone vortioxetine
|
citalopram desvenlafaxine duloxetin eescitalopram fluoxetin eparoxetine pepexev sarafe, sertraline venlafaxine |
Bupropion HCL extended-release |
|
|
Bipolar depression |
Bipolar disorder (mixed Mania/Depression |
Bipolar maintenance |
Mania |
|
|
lithium (used with lurasidone) lurasidone olanzapine-fluoxetine combination (symbyax) quetiapine valproate (divalproex) (used with lurasidone) |
aripiprazole asenapine carbamazepine |
olanzapine ziprasidone |
aripiprazole lamotrigine lithium olanzapine |
aripiprazole asenapine carbamazepine lithium olanzapine quetiapine risperidone valproate (divalproex) ziprasidone |